| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA691210 | F | In vitro concentration which inhibits 80% of serotypes tested | Human rhinovirus sp. | 29 | ALA1128705 | organism-based format | Scientific Literature | |
| 2. | ALA882178 | F | In vitro concentration required to reduce the viability of mock-infected HeLa cells by 50% | Homo sapiens | 29 | ALA1128705 | cell-based format | Scientific Literature | |
| 3. | ALA698789 | F | In vitro concentration required to achieve 50% protection of HeLa cells from HRV-14 induced cytopathic effect | Human rhinovirus sp. | 34 | ALA1128705 | organism-based format | Scientific Literature | |
| 4. | ALA876922 | F | In vitro concentration required to achieve 50% protection of HeLa cells from HRV-2 induced cytopathic effect | 34 | ALA1128705 | cell-based format | Scientific Literature | ||
| 5. | ALA4372126 | F | Antiviral activity against Poliovirus Sabin 1 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 15 | ALA4371031 | organism-based format | Scientific Literature | |
| 6. | ALA4372127 | F | Antiviral activity against Poliovirus Sabin 2 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 2 | 15 | ALA4371031 | organism-based format | Scientific Literature | |
| 7. | ALA4372128 | F | Antiviral activity against Poliovirus Sabin 3 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 3 | 15 | ALA4371031 | organism-based format | Scientific Literature | |
| 8. | ALA4372129 | F | Antiviral activity against Human poliovirus 1 10688 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 9. | ALA4372130 | F | Antiviral activity against Human poliovirus 1 10689 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 10. | ALA4372131 | F | Antiviral activity against Human poliovirus 1 10690 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 11. | ALA4372132 | F | Antiviral activity against Human poliovirus 1 10691 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 12. | ALA4372133 | F | Antiviral activity against Human poliovirus 1 10692 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 13. | ALA4372134 | F | Antiviral activity against Human poliovirus 1 10693 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 14. | ALA4372135 | F | Antiviral activity against Human poliovirus 1 10694 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 15. | ALA4372136 | F | Antiviral activity against Human poliovirus 1 10695 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 16. | ALA4372137 | F | Antiviral activity against Human poliovirus 1 10222 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 17. | ALA4372138 | F | Antiviral activity against Human poliovirus 1 10223 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 18. | ALA4372139 | F | Antiviral activity against Human poliovirus 1 10224 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 19. | ALA4372140 | F | Antiviral activity against Human poliovirus 1 10225 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature | |
| 20. | ALA4372141 | F | Antiviral activity against Human poliovirus 1 10235 infected in human HeLa cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by crystal violet staining-based assay | Poliovirus 1 | 3 | ALA4371031 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!